Pathogenica, Illumina to Co-Market HAI BioDetection Kit on MiSeq | GenomeWeb

NEW YORK (GenomeWeb News) – Pathogenica said today that it will co-market with Illumina a new version of its HAI BioDetection kit on Illumina's MiSeq desktop sequencing system in the Asia Pacific region.

The new version of the kit, which uses targeted next-generation sequencing to detect bacterial strains involved in hospital acquired infections, will enable users to identify an expanded panel of bacteria and drug-resistant genes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.